IRME
IR-Med, Inc.Company Information
- Company Name
- IR-Med, Inc.
- CIK
- CIK0001839133
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- IRME: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- IRME
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2025-08-14
- Price on filing date
- —
- 1-month reaction
- -7.53%
- 3-month reaction
- 138.03%
Balance Sheet
Values in millions ($)| Line item | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 2 | 2 | 3 | 4 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 2 | 2 | 3 | 4 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Restricted Investments Noncurrent | - | - | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Restricted Cash And Investments Noncurrent | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
Assets Noncurrent | ||||||||||||||||||
| Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 3 | 4 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Long Term Loans Payable | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Due To Officers Or Stockholders Current | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 1 | 1 | 1 | - | - | - | 0 | 1 | 1 | 1 | 1 | - | ||||||
| Other Liabilities Current | - | - | - | - | - | - | - | - | - | 0 | 0 | - | ||||||
| Loans Payable Current | 0 | 0 | 0 | - | - | - | - | 0 | 0 | - | - | - | ||||||
| Convertible Debt | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Long Term Debt And Capital Lease Obligations | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Due To Officers Or Stockholders Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Liabilities Noncurrent | 0 | - | - | - | - | - | 0 | 0 | 0 | - | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 0 | - | - | - | - | - | - | 0 | - | - | 0 | - | ||||||
| Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 18 | 17 | 16 | 16 | 16 | 15 | 15 | 15 | 14 | 13 | 12 | 11 | ||||||
| Stockholders Equity | -1 | -0 | -0 | 0 | 0 | -0 | 0 | 1 | 2 | 2 | 3 | 4 | ||||||
| Retained Earnings Accumulated Deficit | -18 | -18 | -17 | -16 | -16 | -15 | -15 | -14 | -12 | -11 | -10 | -8 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 3 | 4 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 600 | 600 | 600 | 600 | 600 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | ||||||
| Common Stock Shares Issued | 77 | 72 | 71 | 71 | 71 | 70 | 70 | 70 | 70 | 69 | 69 | 69 | ||||||
| Shares Outstanding | 77 | 72 | 71 | - | - | - | 70 | 70 | 70 | 69 | 69 | 69 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialIR-Med, Inc. (IRME) — SEC Financial Statements & Analysis
IR-Med, Inc. (IRME) is a electromedical & electrotherapeutic apparatus company, incorporated in NV. IR-Med, Inc. trades on OTC as: IRME. IR-Med, Inc. (IRME)'s most recent SEC filing is a Form 10-Q for the period ended 2025-06-30, filed with the SEC on 2025-08-14. Based on that filing, IR-Med, Inc. carries a market cap of $4.43M, a P/E ratio of 1.88x, a P/B ratio of -7.08x, an enterprise value of $4.57M, and an EV/EBITDA multiple of 3.08x. On profitability, it posts a Return on Equity (ROE) of -1793.89% and a Return on Assets (ROA) of 442.56%. Per share, it reports EPS of $0.03, diluted EPS of $0.03, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -32.34% year-over-year and EPS growth of -35.52% year-over-year. On the balance sheet, it maintains a current ratio of 0.12x, a quick ratio of 0.12x, working capital of $-684.00K, a debt-to-equity ratio of -1.28x, a debt ratio of 4.57, free cash flow of $-837.00K (TTM), and net debt of $145.00K. Figures sourced from SEC EDGAR.
- Market Cap
- $4.43M
- P/E TTM
- 1.88x
- EPS TTM
- $0.03
- P/B TTM
- -7.08x
- ROE TTM
- -1793.89%
- ROA TTM
- 442.56%
- Debt To Equity
- -1.28x
- Free Cash Flow TTM
- $-837.00K
Data as of 2025-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is IR-Med, Inc. in?
IR-Med, Inc. (IRME) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does IRME trade on?
IR-Med, Inc. (IRME) trades on the OTC.
Where is IR-Med, Inc. incorporated?
IR-Med, Inc. is incorporated in NV.
When was IR-Med, Inc. (IRME)'s most recent SEC filing?
IR-Med, Inc. (IRME)'s most recent SEC filing is a Form 10-Q for the period ended 2025-06-30, filed with the SEC on 2025-08-14.
What is IRME's market cap?
IR-Med, Inc. (IRME) has a market capitalization of $4.43M as of 2025-06-30.
What is IRME's P/E ratio?
IR-Med, Inc. (IRME)'s trailing twelve month P/E ratio is 1.88x as of 2025-06-30.
What is IRME's EPS (earnings per share)?
IR-Med, Inc. (IRME)'s trailing twelve month EPS is $0.03 as of 2025-06-30.
What is IRME's ROE (return on equity)?
IR-Med, Inc. (IRME)'s trailing twelve month Return on Equity (ROE) is -1793.89% as of 2025-06-30.
What is IRME's ROA (return on assets)?
IR-Med, Inc. (IRME)'s trailing twelve month Return on Assets (ROA) is 442.56% as of 2025-06-30.
What is IRME's EV/EBITDA?
IR-Med, Inc. (IRME)'s trailing twelve month EV/EBITDA is 3.08x as of 2025-06-30.